Nav: Home

Molecules from breast milk and seaweed suggest strategies for controlling norovirus

July 26, 2018

Norovirus is the most common cause of gastroenteritis worldwide; it causes tens hundreds of thousands of deaths each year and is particularly risky for children under 3 years old. If someone gets norovirus in a setting like a hospital, it's critically important to find a way to protect others from getting infected. New research from several universities in Germany, to be published in the Journal of Biological Chemistry, suggests that it may be easier than anticipated to find a compound that could be used as a food supplement to stop the spread of norovirus in children's hospitals.

Norovirus causes disease after entering cells in the gut by binding to a sugar molecule called fucose, which is found on cell surfaces as part of the structure that determines human ABO blood types. Fucose is also found in breast milk and other foods. Norovirus can't tell the difference between fucoses that are part of cells in the gut and those that are simply passing through; for this reason, adding a fucose-based supplement to the diet as a decoy could be a way to capture the virus and keep it from infecting cells.

To develop this strategy, however, researchers needed to understand which features of fucose and virus molecules affected how well they attached to each other. In cells, foods, and milk, fucose is rarely found as a single molecule; rather, it's part of chains or networks of sugars and proteins. Franz-Georg Hanisch, a researcher at the University of Cologne, led a project to disentangle these molecular elements and understand what kind of fucose-based product would best distract noroviruses. He started by screening the many types of fucose-containing human milk oligosaccharides (HMOs).

To Hanisch's surprise, the strength of the binding between the norovirus protein and HMOs did not depend much on the specific structure of the HMO, or the types of fucose molecules it contained. Rather, what mattered was only how many fucoses it contained. Each individual fucose stuck weakly to the virus protein, but the more fucoses there were in the compound, the better the compound and the viral protein stuck together.

"The binding of the virus is not dependent in any way on further structural elements (of HMOs)," Hanisch said. "It's only the terminal fucose which is recognized, and the more fucose at higher densities is presented, the better is the binding."

Hanisch then turned to the industry standard of where to get a lot of fucose fast. Brown algae - the same family of seaweed that includes kelp - produce a compound called fucoidan, which is a complex network of many fucoses. (Fucoidan has independently been explored as a treatment for HIV, CMV, and HSV for unrelated biochemical reasons.)

"There are procedures for isolating the stuff in quite high yields and in high purity," Hanisch said.

The organization of the fucose in fucoidans looks nothing like any fucose-containing molecules found in the human body, but fucoidan nevertheless tightly bound to the virus protein in the team's experiments. This is good news, because it means that fucoidan could be a safe and cheap food additive to block viruses from infecting cells. It also suggests that the sky is the limit for researchers to design an even better fucose-containing compound.

Hanisch and his collaborators are therefore now moving on to experiments with live viruses and live organisms. The hope is to eventually have a fucose-based food supplement that could be given to a group of people, like hospitalized children, at the first sign of a norovirus outbreak, to prevent the circulating viruses from entering their cells and causing disease.

"I hope that in about three years we will have a product which can be used in norovirus defense and to go into clinical studies," Hanisch said.
-end-
The study was funded by the CHS Foundation, the Helmholtz-Chinese Academy of Sciences, and Deutsche Forschungsgemeinschaft.

About the Journal of Biological Chemistry

JBC is a weekly peer-reviewed scientific journal that publishes research "motivated by biology, enabled by chemistry" across all areas of biochemistry and molecular biology. The read the latest research in JBC, visit http://www.jbc.org/.

About the American Society for Biochemistry and Molecular Biology

The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, at nonprofit research institutions and in industry. The Society's student members attend undergraduate or graduate institutions. For more information about ASBMB, visit http://www.asbmb.org.

American Society for Biochemistry and Molecular Biology

Related Breast Milk Articles:

Compound in breast milk fights harmful bacteria
A compound in human breast milk fights infections by harmful bacteria while allowing beneficial bacteria to thrive, according to researchers at National Jewish Health and the University of Iowa.
Study finds certain drugs used to treat eye diseases excreted into human breast milk
Ranibizumab and aflibercept are medications used to treat several retinal diseases.
Breast milk analyses show new opportunities for reducing risk of childhood obesity
The composition of breast milk in normal weight mothers differs from that of overweight mothers, and variations in small molecule metabolites found in breast milk are possible risk factors for childhood obesity.
Can human breast milk reduce intestinal injury following bone marrow transplant?
A new pilot study compared the use of human breast milk to formula in children less than five years of age who underwent bone marrow transplant, measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.
Breast milk as drug-delivery device
Treating sick babies with engineered breast milk could someday be a reality, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
Breast milk microbiome contains yeast and fungi: Do these benefit the infant?
Investigators have now shown that the breast milk microbiome contains fungi.
Breast milk & babies' saliva shape oral microbiome
Newborn breastfed babies' saliva combines with breastmilk to release antibacterial compounds that help to shape the bacterial communities (microbiota) in babies' mouths, biomedical scientists have found.
Breast milk, formula nurture similarities, differences in gut microbes
Baby formula is designed to mimic human breast milk as closely as possible.
Breast milk may be best for premature babies' brain development
Babies born before their due date show better brain development when fed breast milk rather than formula, a study from the University of Edinburgh has found.
Scientists identified enzyme in milk production as target for novel breast cancer drugs
VCU Massey Cancer Center researchers have identified a protein involved in milk production that stimulates the growth and spread of breast cancer and could ultimately serve as a target for novel therapies to treat breast cancer.
More Breast Milk News and Breast Milk Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.